User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 12:54, 25 February 2021 Homo sapiens:Liver steatosis adverse outcome pathway (Ontology Term : 'hepatocyte' added !)
- 12:52, 25 February 2021 Homo sapiens:Liver steatosis adverse outcome pathway (Ontology Term : 'fatty liver disease' added !)
- 17:31, 21 February 2021 Homo sapiens:Genes associated with the development of rheumatoid arthritis (Ontology Term : 'rheumatoid arthritis' added !)
- 17:13, 11 February 2021 Homo sapiens:Liver steatosis adverse outcome pathway (updated KE title of KE66)
- 17:11, 11 February 2021 Homo sapiens:Liver steatosis adverse outcome pathway (Added Key Event type to KE66)
- 10:49, 11 February 2021 Homo sapiens:Liver steatosis adverse outcome pathway
- 10:48, 11 February 2021 Homo sapiens:Liver steatosis adverse outcome pathway
- 10:31, 8 January 2021 Homo sapiens:Angiotensin II receptor type 1 pathway (small graphical update)
- 11:21, 7 January 2021 Homo sapiens:Angiotensin II receptor type 1 pathway (Added pathway link for coagulation)
- 11:18, 7 January 2021 Homo sapiens:Angiotensin II receptor type 1 pathway (Updated layout, added link to coagulation)
- 10:58, 7 January 2021 Homo sapiens:Angiotensin II receptor type 1 pathway (rounded rectangles for pathways)
- 10:57, 7 January 2021 N Homo sapiens:Angiotensin II receptor type 1 pathway (New pathway)
- 08:52, 7 January 2021 Homo sapiens:ACE2 inhibition leads to pulmonary fibrosis
- 08:51, 7 January 2021 Homo sapiens:ACE2 inhibition leads to pulmonary fibrosis
- 08:38, 7 January 2021 AOP/FeaturedPathways (top)
- 17:37, 6 January 2021 N Homo sapiens:ACE2 inhibition leads to pulmonary fibrosis (New pathway)
- 17:15, 6 January 2021 AOP/Mission
- 17:06, 6 January 2021 AOP/FeaturedPathways
- 17:02, 6 January 2021 N Homo sapiens:Mitochondrial complex inhibition leading to liver injury (New pathway)
- 16:15, 6 January 2021 Homo sapiens:Protein alkylation leading to liver fibrosis (Updated layout)
- 16:06, 6 January 2021 Homo sapiens:Protein alkylation leading to liver fibrosis (Renewed and removed molecular entities to follow AOP guidelines)
- 12:03, 6 January 2021 AOP/Mission
- 17:47, 30 November 2020 Homo sapiens:RAS and bradykinin pathways in COVID-19 (Added bits downstream of bradykinin receptors)
- 12:31, 27 November 2020 AOP/FeaturedPathways
- 19:48, 12 October 2020 FileFormats
- 20:34, 8 October 2020 AOP/Mission
- 10:14, 18 September 2020 Homo sapiens:Fluoroacetic acid toxicity (Ontology Term : 'altered metabolic pathway' added !)
- 10:14, 18 September 2020 Homo sapiens:Fluoroacetic acid toxicity (Ontology Term : 'altered citric acid cycle pathway' added !)
- 10:09, 18 September 2020 Homo sapiens:Fluoroacetic acid toxicity (Added reference and minor layout edit)
- 19:16, 8 September 2020 Homo sapiens:Fluoroacetic acid toxicity (changed secondary chebi IDs to primary chebi IDs.)
- 14:17, 7 September 2020 N Homo sapiens:Fluoroacetic acid toxicity (New pathway)
- 09:58, 21 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Ungrouped for nicer network merging)
- 09:57, 21 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome (ungrouped groups for better network merging)
- 09:53, 21 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome (Aligned layout better)
- 09:51, 21 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (changed connections in groups)
- 09:44, 21 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome (Changed connections in groups to test for merging)
- 11:32, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits
- 11:23, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome (Ontology Term : 'altered metabolic pathway' added !)
- 11:14, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Modified description)
- 11:13, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Added literature reference)
- 11:02, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Ontology Term : 'altered energy metabolic pathway' added !)
- 10:38, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Ontology Term : 'Parkinson's disease' added !)
- 10:37, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Ontology Term : 'DOID:0060897' removed !)
- 10:37, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Ontology Term : 'Parkinson disease 17' added !)
- 10:36, 7 August 2020 Homo sapiens:Mitochondrial complex I inhibition leading to parkinsonian motor deficits (Modified description)
- 10:33, 7 August 2020 Homo sapiens:Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition (Modified description)
- 10:24, 7 August 2020 AOP/News
- 10:21, 7 August 2020 AOP/FeaturedPathways
- 10:20, 7 August 2020 AOP/FeaturedPathways
- 12:22, 5 August 2020 Homo sapiens:DNA repair pathways, full network (Ontology Term : 'DNA repair pathway' added !)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
